Evidence map›Paper›PMID 36105393›Full record

ArticleFrontiers in endocrinology2022

Interhemispheric asymmetry of the brain in patients with type 1 diabetes mellitus and cognitive impairment.

Yulia Gennadevna Samoilova, Mariia Vladimirovna Matveeva, Olga Sergeevna Tonkih, Dmitry Anatolievich Kudlay, Oxana Alekseevna Oleynik, Stephen Olaide Aremu, Oksana Yurievna Kilina, Alexander Federovich Kanev, Olga Mihailovna Gerget

Open access · goldAbstract read
In one paragraph

Article in Frontiers in endocrinology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Yulia Gennadevna SamoilovaDepartment of Children Diseases, Siberian State Medical University, Tomsk, Russia.
Mariia Vladimirovna MatveevaDepartment of Children Diseases, Siberian State Medical University, Tomsk, Russia.
Olga Sergeevna TonkihDepartment of Tomographic Research Methods, Siberian State Medical University, Tomsk, Russia.
Dmitry Anatolievich KudlayDepartment of Pharmacology, Ivan Mikhailovich Sechenov First Moscow State Medical University, Moscow, Russia.
Oxana Alekseevna OleynikDepartment of Children Diseases, Siberian State Medical University, Tomsk, Russia.
Stephen Olaide AremuDepartment of Children Diseases, Siberian State Medical University, Tomsk, Russia.
Oksana Yurievna KilinaDepartment of Internal Medicine, Katanov Khakass State University, Abakan, Republic of Khakassia, Russia.
Alexander Federovich KanevDepartment of Internal Medicine with a Course of Therapy of Pediatrics Faculty, Siberian State Medical University, Tomsk, Russia.
Olga Mihailovna GergetDepartment of Information Technology of the Engineering School of Information Technology and Robotics, Tomsk Polytechnic University, Tomsk, Russia.
Siberian State Medical University · RUKhakassian State University named after N.F. Katanov · RUNational Research Tomsk State University · RUSechenov University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With an ageing of population and a splurging epidemic of diabetes mellitus (DM), the prevalence of complications associated with pathology of the central nervous system are expected to increase, which in the future may have serious consequences for public health. It is known that one of the main manifestations of brain damage in type 1 diabetes is cognitive impairment, which is possibly associated with the peculiarities of vascularization and interhemispheric asymmetry, which requires in-depth analysis using modern neuroimaging methods. The aim of the study is to assess the symmetry of structural, metabolic and neurovascularization changes in the brain in patients with type 1 diabetes and cognitive impairment. The study included 120 patients with type 1 diabetes aged 18 to 45 years suffering from cognitive impairment, and 30 people without cognitive decline and the control group (n=30) healthy people without diabetes. Neuropsychological testing included the Montreal Cognitive Dysfunction Assessment Scale (MoCA test). For neuroimaging methods, standard magnetic resonance imaging (MRI), magnetic resonance spectroscopy (MRS), contrast and non-contrast-enhanced perfusion were used. Statistical processing was carried out using the SPSS Statistic 2020 software. In patients with type 1 diabetes with cognitive impairment, as manifested by impaired memory and/or attention, perfusion imaging revealed the presence of brain asymmetry zones. Standard MRI allowed to demonstrate changes in the white, gray matter and hippocampus in the right hemisphere. The results obtained were refined taking into account the topical localization, so during the perfusion study, regions with asymmetric blood flow were identified - namely, the white matter of the frontal lobe and the gray matter in the occipital lobe. Spectroscopy of the brain revealed that it was in these areas of the brain that the most significant metabolic disorders were noted - in the form of significantly altered ratio of N-acetylaspartate (NAA)/choline (Cho) on the left, along with the asymmetry in phosphocreatine level (Cr 2) on the right. In conclusion, early preclinical predictive diagnostics with the use of modern neuroimaging methods allows for timely detection of impaired vascularization and brain metabolism in this group of patients, However, decreased perfusion in the region within the region of frontal lobe white matter and temporal lobe grey matter, and hippocampal cell metabolism by spectra should be highlighted among the parameters Cr right and NAA/Cho left.

Indexed as

Cognitive DysfunctionDiabetes Mellitus, Type 1BrainCholineHumansMagnetic Resonance ImagingMagnetic Resonance SpectroscopyCholinebraincognitive impairmentinterhemispheric asymmetryneuroimagingtype 1 diabetes mellitus

Identifiers

PMID36105393
PMCPMC9465454
OpenAlexW4293426467

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.